“We got neutrons, yeah!” The shout came after years of after-school effort inside a Dallas home, where a seventh grader had been quietly assembling a machine most people only encounter in advanced ...
At just twelve years old, Aiden McMillan has built a working nuclear fusion device in his family home in Dallas, Texas. He spent four years researching and assembling the machine, then confirmed ...
A 12-year-old student from Dallas is making waves after successfully achieving nuclear fusion in his playroom. According to NBC News, Aiden McMillan, a Class 7 student in the Dallas Independent School ...
A science project puts Dallas 7th-grader on path to a world record. X.Com A 12-year-old schoolboy from Dallas has attracted global attention after successfully producing nuclear fusion and setting his ...
Add Yahoo as a preferred source to see more of our stories on Google. Feb. 10 (UPI) --A 12-year-old Dallas student's four-year-long science project may have resulted in his becoming the youngest ...
Feb. 10 (UPI) --A 12-year-old Dallas student's four-year-long science project may have resulted in his becoming the youngest person to ever achieve nuclear fusion. Aiden McMillan, a Dallas Independent ...
An awe-inspiring science project by a Dallas ISD seventh-grader is now drawing national attention, as the student works to secure a Guinness World Record as the youngest person to achieve nuclear ...
Forward-looking: For decades, fusion energy has been hailed as the ultimate clean-power breakthrough – a virtually limitless source of electricity that mimics the reactions fueling the Sun. Yet one of ...
The big picture: For decades, the promise of fusion power seemed just out of reach – a theoretical miracle of physics that stubbornly refused to move from blueprint to breaker box. Yet in laboratories ...
Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md., Jan. 12, 2026 /PRNewswire/ -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a ...
NICE is unable to make a recommendation on entrectinib (Rozlytrek) for treating neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumours in people 12 years and over. This is because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results